These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19054640)

  • 1. Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization.
    Ippolito D; Sironi S; Pozzi M; Antolini L; Invernizzi F; Ratti L; Leone EB; Fazio F
    Eur J Radiol; 2010 Jan; 73(1):148-52. PubMed ID: 19054640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.
    Ippolito D; Sironi S; Pozzi M; Antolini L; Ratti L; Alberzoni C; Leone EB; Meloni F; Valsecchi MG; Fazio F
    Acad Radiol; 2008 Jul; 15(7):919-27. PubMed ID: 18572129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfusion computed tomographic assessment of early hepatocellular carcinoma in cirrhotic liver disease: initial observations.
    Ippolito D; Sironi S; Pozzi M; Antolini L; Ratti L; Meloni F; Invernizzi F; Valsecchi MG; Fazio F
    J Comput Assist Tomogr; 2008; 32(6):855-8. PubMed ID: 19204443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging.
    Ippolito D; Capraro C; Casiraghi A; Cestari C; Sironi S
    Eur Radiol; 2012 Apr; 22(4):803-11. PubMed ID: 22086560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
    Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
    Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor.
    Ippolito D; Bonaffini PA; Ratti L; Antolini L; Corso R; Fazio F; Sironi S
    World J Gastroenterol; 2010 Dec; 16(47):5993-6000. PubMed ID: 21157976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viable residual tumor tissue after radiofrequency ablation treatment in hepatocellular carcinoma: evaluation with CT perfusion.
    Ippolito D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
    Abdom Imaging; 2013 Jun; 38(3):502-10. PubMed ID: 22743839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study.
    Ippolito D; Querques G; Okolicsanyi S; Franzesi CT; Strazzabosco M; Sironi S
    Eur J Radiol; 2017 May; 90():34-41. PubMed ID: 28583645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of hepatocellular carcinoma (HCC) lesions using a novel CT-based volume perfusion (VPCT) technique.
    Kaufmann S; Horger T; Oelker A; Kloth C; Nikolaou K; Schulze M; Horger M
    Eur J Radiol; 2015 Jun; 84(6):1029-35. PubMed ID: 25816994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraobserver and Interobserver Agreement in the Evaluation of Tumor Vascularization With Computed Tomography Perfusion in Cirrhotic Patients With Hepatocellular Carcinoma.
    Ippolito D; Casiraghi AS; Talei Franzesi C; Bonaffini PA; Fior D; Sironi S
    J Comput Assist Tomogr; 2016; 40(1):152-9. PubMed ID: 26484957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of tumor vascularization with functional computed tomography perfusion imaging in patients with cirrhotic liver disease.
    Li JP; Zhao DL; Jiang HJ; Huang YH; Li DQ; Wan Y; Liu XD; Wang JE
    Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):43-9. PubMed ID: 21269934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.
    Kaufmann S; Schulze M; Spira D; Horger M
    Acta Radiol; 2016 Jan; 57(1):8-12. PubMed ID: 25585848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver perfusion CT during hepatic arteriography for the hepatocellular carcinoma: dose reduction and quantitative evaluation for normal- and ultralow-dose protocol.
    Watanabe S; Katada Y; Gohkyu M; Nakajima M; Kawabata H; Nozaki M
    Eur J Radiol; 2012 Dec; 81(12):3993-7. PubMed ID: 22980216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic blood volume imaging with the use of flat-detector CT perfusion in the angiography suite: comparison with results of conventional multislice CT perfusion.
    Zhuang ZG; Zhang XB; Han JF; Beilner J; Deuerling-Zheng Y; Chi JC; Wang J; Qian LJ; Zhou Y; Xu JR
    J Vasc Interv Radiol; 2014 May; 25(5):739-46. PubMed ID: 24745904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?
    Kurucay M; Kloth C; Kaufmann S; Nikolaou K; Bösmüller H; Horger M; Thaiss WM
    Cancer Imaging; 2017 Jun; 17(1):18. PubMed ID: 28659180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases.
    Perl RM; Portugall J; Hinterleitner C; Hinterleitner M; Kloth C; Walter SS; Bitzer M; Horger MS
    Anticancer Res; 2021 Mar; 41(3):1451-1458. PubMed ID: 33788737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience.
    Sahani DV; Holalkere NS; Mueller PR; Zhu AX
    Radiology; 2007 Jun; 243(3):736-43. PubMed ID: 17517931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiphasic Dynamic Computed Tomography Evaluation of Liver Tissue Perfusion Characteristics Using the Dual Maximum Slope Model in Patients With Cirrhosis and Hepatocellular Carcinoma: A Feasibility Study.
    Lee DH; Lee JM; Klotz E; Han JK
    Invest Radiol; 2016 Jul; 51(7):430-4. PubMed ID: 26756941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hepatocellular carcinoma with computed tomography perfusion imaging.
    Bayraktutan Ü; Kantarci A; Oğul H; Kizrak Y; Özyiğit Ö; Yüceler Z; Genç B; Özoğul B
    Turk J Med Sci; 2014; 44(2):193-6. PubMed ID: 25536723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfusion-CT analysis for assessment of hepatocellular carcinoma lesions: diagnostic value of different perfusion maps.
    Hatzidakis A; Perisinakis K; Kalarakis G; Papadakis A; Savva E; Ippolito D; Karantanas A
    Acta Radiol; 2019 May; 60(5):561-568. PubMed ID: 30114926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.